Demand and need for the leading oncology medicine manufacturer in Chandigarh are increasing steadily for a variety of reasons that influence both the domestic and international pharmaceutical markets. Among these various demand factors, industry trends allow Chandigarh to become the favoured location for oncology pharmaceutical manufacturing. However, if we talk about the rising cancer rates in India. India estimates about 1.5 million new cancer cases each year, boosting the demand for dependable and economical oncology treatments. Therefore, it has been seen that oncologists and hospitals are increasingly turning to Indian manufacturers for cost-effective generics and tailored therapy. Along with this, Ayushman Bharat, a government healthcare plan, promotes the adoption of low-cost cancer medications. This means manufacturers in Chandigarh are in huge demand to create low-cost cancer generics that fulfil high demand in both the public and private sectors.
Besides all of that, the pharma ecosystem in Chandigarh, including adjacent Baddi, is increasing. The proximity to Baddi (Asia’s largest pharma hub) allows access to WHO-GMP-approved establishments and also a skilled pharmaceutical workforce. Consequently, this all reflects the huge business demand and scope for the oncology third-party medicine manufacturers in Chandigarh.
Manufacturing of top-quality medicines by the top oncology medicine manufacturer in Chandigarh, Spica Drugs.
Because oncology therapies are so vital, the production of high-quality cancer medicine solutions requires a highly regulated, precise, and technically advanced process. Here’s an outline of our company’s important components and stages involved in creating high-quality cancer medications (both oral and injectable forms):
- Research and development: In the beginning, we do some preclinical studies and also conduct in vitro and in vivo tests to assess efficacy and safety. This allows clinical trials to involve human testing in stages to determine dose, efficacy, adverse effects, and long-term impact. Finally, we create stable and bioavailable dosage forms (such as tablets, injectables, and capsules).
- GMP-compliant manufacturing facilities: WHO-GMP or EU-GMP certification is the main element of our medicines’ quality. For this, we have developed cleanrooms with effective air filtration (HEPA filters) and temperature control rooms. This allows us to always prevent contamination, with high-potency APIs stored in separate locations. We also take the proper use of the automated and computerised controls to monitor crucial parameters.
- Sourcing and testing raw materials: Our team of certified vendors always provides high-quality active pharmaceutical ingredients (APIS). This includes strict quality control checks for identity, purity, potency, and microbial limits.
- Manufacturing process for oral solid dosage (tablets, capsules): Ins, I have added the process of the
- Granulation (wet/dry)
- Blending and compression
- Coating & packaging
- Injectable solutions require aseptic preparation.
- Filtration and sterilisation
- Filling in vials or pre-filled syringes
- Lyophilisation (freeze-drying) of certain medications
- Quality control and assurance: as the trusted and top oncology medicine manufacturing company, we also take care of the in-process control during production.
- Final product testing:
- Assay
- Dissolution
- Sterility
- Endotoxins
- Stability tests to assess shelf life
- Batch record review and qa release.
- Packaging and logistics: We always ensure that all of our medicines are packed in tamper-proof and safe packaging and cold chain logistics for temperature-sensitive medicines. We have also included regulatory-compliant labeling, including expiry dates, batch numbers, usage, and cautions.
Oncology medicine demand in India (2024–2025)
Oncology (cancer) medicine demand in India has increased rapidly and steadily, owing to a variety of demographic, medical, and policy drivers. Market overview of these medicines defines the size of the Indian oncology drug market by 2025 as estimated to be worth more than INR 3,000 crore and expanding at a CAGR of 12-15 per cent. With this, by 2030, India is predicted to be one of the top ten global markets for cancer treatments. As a result, this market includes medications for chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. Furthermore, according to the ICMR, around 1.5 million new cancer cases are detected in India each year. Therefore, common types, including breast, cervical, lung, colorectal, and prostate cancers, are in high demand. The demand for these medicines is affected by various factors, like developing healthcare infrastructure, which includes an increase in cancer hospitals, oncology departments, and super-speciality centres.
Moreover, there is a rapidly increasing demand for affordable generic and biosimilar drugs. Indian pharmaceuticals are a key global provider of inexpensive generics. As a result, the growing adoption of biosimilars is making targeted therapy more accessible and increasing the demand for trustworthy third-party producers of oncology medicines.
Final result
Finally, we want to tell you that Spica Drugs is the best platform to choose a reliable oncology medicine manufacturer in Chandigarh. Moreover, we have proven the huge business demand for these medicines today and in the future as well. Hence, for these medicine dealers, this is the perfect professional deal to get our services.
Contact Details
Ph: +91-8949055013 , 0172-5020013
Email: info@janusbiotech.in